Borosil Scientific Ltd Valuation Shifts Signal Changing Price Attractiveness

1 hour ago
share
Share Via
Borosil Scientific Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting evolving market perceptions amid strong price performance and improving fundamentals. This article analyses the recent changes in key valuation metrics, compares them with peer averages and historical benchmarks, and assesses what this means for investors eyeing the industrial products sector.
Borosil Scientific Ltd Valuation Shifts Signal Changing Price Attractiveness

Valuation Metrics Reflect Elevated Market Expectations

As of mid-June 2026, Borosil Scientific Ltd trades at ₹155.20, up 1.44% on the day from a previous close of ₹153.00. The stock has demonstrated robust momentum over the past month, surging 30.53%, significantly outperforming the Sensex’s 2.09% gain in the same period. Year-to-date, Borosil has delivered a 29.28% return, contrasting sharply with the Sensex’s negative 9.87% performance, underscoring strong investor appetite.

However, this price appreciation has been accompanied by a shift in valuation perception. The company’s price-to-earnings (P/E) ratio currently stands at 33.14, a level that has pushed its valuation grade from 'fair' to 'expensive' according to MarketsMOJO’s assessment. This P/E is notably higher than several peers in the industrial products sector, signalling elevated market expectations for future earnings growth.

Price-to-book value (P/BV) has also increased to 3.20, reinforcing the premium investors are willing to pay relative to the company’s net asset base. Other valuation multiples such as EV/EBITDA at 20.62 and EV/EBIT at 29.86 further highlight the stretched nature of Borosil’s current market pricing compared to historical averages.

Peer Comparison Highlights Relative Valuation Position

When compared with key competitors, Borosil’s valuation appears expensive but not without justification. Saint-Gobain Sekurit, a major peer, is rated as 'very expensive' with a P/E of 25.1 and EV/EBITDA of 18.49, both lower than Borosil’s multiples. Meanwhile, companies like Haldyn Glass and Empire Industries are classified as 'attractive' or 'very attractive' with P/E ratios of 25.26 and 12.07 respectively, and significantly lower EV/EBITDA multiples of 12.25 and 7.82.

Some peers such as Jai Mata Glass, FGP, and Triveni Glass are marked as 'risky' due to loss-making operations or extreme valuation metrics, which contrasts with Borosil’s stable profitability and positive return ratios. Agarwal Toughene, another peer, is rated 'expensive' but trades at a much lower P/E of 10.39 and EV/EBITDA of 8.5, indicating Borosil’s premium is substantial within the sector.

This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!

  • - Precise target price set
  • - Weekly selection live
  • - Position check opportunity

Check Your Position →

Financial Performance Supports Premium Valuation

Borosil Scientific’s return on capital employed (ROCE) stands at a healthy 13.69%, while return on equity (ROE) is 9.64%. These figures indicate efficient utilisation of capital and reasonable profitability, which partly justify the premium multiples. The company’s PEG ratio of 1.08 suggests that the price is somewhat aligned with expected earnings growth, although it is on the higher side compared to peers like Empire Industries (0.24) and Haldyn Glass (0.65).

Despite the premium, Borosil’s valuation remains supported by its micro-cap status and growth trajectory. The stock’s 52-week high of ₹190.45 and low of ₹96.65 illustrate significant price appreciation over the past year, reflecting improved investor confidence and operational momentum.

Market Returns and Risk Considerations

Examining returns over various time frames reveals Borosil’s strong relative performance. Over one year, the stock has gained 10.11%, while the Sensex declined by 6.10%. Year-to-date returns of 29.28% further highlight the stock’s outperformance. However, longer-term data is not available for Borosil, unlike the Sensex which has delivered 21.18% and 46.30% returns over three and five years respectively.

Investors should note that the shift to an expensive valuation grade signals increased risk if earnings growth fails to meet elevated expectations. The absence of a dividend yield also means returns are reliant solely on capital appreciation. Nonetheless, the company’s stable fundamentals and improving market sentiment have led MarketsMOJO to upgrade its mojo grade from 'Hold' to 'Buy' as of 10 June 2026, with a mojo score of 71.0.

Curious about Borosil Scientific Ltd from Industrial Products? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!

  • - Detailed research coverage
  • - Technical + fundamental view
  • - Decision-ready insights

Get the Complete Analysis →

Implications for Investors and Outlook

The recent upgrade in Borosil Scientific’s mojo grade to 'Buy' reflects a positive outlook driven by strong price momentum and solid financial metrics. However, the transition to an expensive valuation grade warrants caution. Investors should weigh the premium multiples against the company’s growth prospects and sector dynamics.

Given the industrial products sector’s cyclical nature, Borosil’s ability to sustain earnings growth and improve return ratios will be critical to justify its current valuation. The company’s micro-cap status offers potential for further upside but also entails higher volatility compared to larger peers.

In summary, Borosil Scientific Ltd presents an attractive growth story with a valuation that has shifted to a premium level. This makes it a compelling but nuanced investment opportunity, best suited for investors with a moderate risk appetite and a focus on long-term capital appreciation.

Summary of Key Valuation and Performance Metrics:

  • P/E Ratio: 33.14 (Expensive grade)
  • Price to Book Value: 3.20
  • EV/EBITDA: 20.62
  • ROCE: 13.69%
  • ROE: 9.64%
  • PEG Ratio: 1.08
  • Mojo Score: 71.0 (Buy, upgraded from Hold on 10 June 2026)
  • Market Cap Grade: Micro-cap

Investors should continue to monitor quarterly earnings and sector trends to assess whether Borosil Scientific can maintain its growth trajectory and justify its premium valuation.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News